The Regional Health Contracting Office-Central (RHCO-C) is issuing this Sources Sought Notice to find potential sources to provide Rapid Fetal Fibronectin Cassettes and Rapid Fetal Fibronectin Control Kits that is compatible with the Adeza TLI IQ System for the Brooke Army Medical Center (BAMC) Department of Pathology and Area Laboratory Services Immunology Laboratory, Fort Sam Houston, Texas.  A base period of performance plus four (4) option periods are contemplated.

THIS IS NOT A SOLICITATION ANNOUNCEMENT – This is a Sources Sought Notice and is issued solely for information and planning purposes – it does not constitute a Request for Quote (RFQ) or a promise to issue an RFQ in the future.  Solicitations are not available at this time and requests for a
solicitation will not receive a response.  This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever.  All information submitted in response to this announcement is voluntary; the United States Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the United States Government. Not responding to this Sources Sought Notice does not preclude participation in any future RFQ, should one be issued.  It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement.

The Government will use responses to this notice in formulating its acquisition strategy. If the Government does not receive sufficient information in response to this notice to verify the potential for competition exists, it is possible that a sole-source contract, supported by a Justification and Approval document, will be issued to support the Government's requirement. RHCO-C is seeking the following information (please answer paragraph below with your response):

1.    Company name, DUNS number, CAGE code, and point of contact information (including phone
number and email address), and socio-economic category(ies) as related to NAICS 325413 (In- Vitro
Diagnostic Substance Manufacturing), such as 8(a), HUBZone, Women-Owned, Service- Disabled
Veteran-Owned, Small, or Other-than-Small.

2.    Capability Statement (limited to ten pages), describing how your company meets the below
objectives, providing additional proof (such as FDA approval) where appropriate:

a.    Fetal Fibronectin Reagents Must be compatible with current instrumentation, Adeza TLI IQ
stem.

b.    Must provide Quality Control materials and test strips on single use disposable cassettes.

c.    Must have negative predictive value of preterm delivery greater than or equal to 95%.

d.     Must provide tests results within two hours of start of test.

e.    Must have a shelf life of greater than or equal to one year.

The response due date for this Sources Sought Notice is 4:00 PM CST, August 27, 2021.  All
questions and comments regarding this announcement shall be submitted via e-mail to the below POCs: